Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients
Recruiting
Observational Study
Septic Shock
Disseminated Intravascular Coagulation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Septic shock is common complication in patients with critical illnesses, with higher incidence in low and medium income countries like ours. Disseminated intravascular coagulation (DIC) is also common in patients presenting to intensive care units. Further DIC is common coexisting condition seen in many patients presenting with sepsis and septic shock.
Both DIC and septic shock individually are a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult ICU patients having septic shock as defined by Sepsis -3 definition requiring vasopressor for at least 12 hours duration will be considered.
Exclusion Criteria:
* Patient having septic shock duration either less than 12 hours or more than 24 hours at the time of the in…
Contacts